Monday, September 7, 2020

Carey Business School Hosts Drug Pricing Symposium

Main navigation Johns Hopkins Legacy Online programs Faculty Directory Experiential studying Career assets Alumni mentoring program Util Nav CTA CTA Breadcrumb Carey Business School Hosts Drug Pricing Symposium The Johns Hopkins Carey Business School will host an all-day symposium March 19, 2018, on preserving consumer entry within the complicated pharmaceuticals marketplace. The Johns Hopkins Carey Business School will host an all-day symposium March 19, 2018, on preserving shopper access within the advanced pharmaceuticals market. The event, to be held at Carey’s Harbor East campus, is directed by Stacey B. Lee, a Carey associate professor with expertise in health law and a member of the core college at the Johns Hopkins Bloomberg School of Public Health. The keynote tackle will be offered by Dan Liljenquist, Vice President of Enterprise and Initiative at Intermountain Healthcare. Liljenquist is a frontrunner in pension reform and healthcare consulting, and he is a former Utah state senator. In January 2018, Intermountain introduced the launch of a nonprofit generic drug firm that has the potential for significant market disruption. The Utah-based healthcare organization leads the proje ct, joined by Ascension, SSM Health, and Trinity Health, in consultation with the U.S. Department of Veterans Affairs. The new company intends to be an FDA approved drug producer. “This is the best time to host a forum on this issue,” says Lee. “The state of Maryland just lately handed groundbreaking legislation defending consumers. The Carey Business School is excited to convene national leaders in Baltimore for this important dialogue. We will definitely have a day filled with ideas and innovation.” Adds Lee: “The skyrocketing worth of medication is a top concern in public health, in policy, and in business research. There are gaps between companies’ objectives and affected person needs. This occasion convenes leaders from across the panorama. We will open dialogue, build trust, and scan the horizon for solutions. In the end, we all want shoppers to be able to afford the life-saving medicine they need.” The day’s panel discussions will gather specialists from throu ghout the nation, including researchers, policy leaders, practitioners, and business executives. Scheduled Jay Bhattacharya of the Stanford University School of Medicine, Jennifer Miller and Alison Bateman-House of the New York University School of Medicine, Joanna Shepherd of the Emory University School of Law, Sharon Glave Frazee of the Pharmacy Benefits Management Institute, Christopher Robertson of the University of Arizona’s James E. Rogers College of Law, and David Yakimischak (Carey MBA, ’sixteen) of ConnectiveRx. Academicians from across Johns Hopkins University may even participate. Among them might be Gerard Anderson and William Padula of the Bloomberg School, who both played a task in the Maryland laws proscribing price will increase on generic pharmaceuticals. Faculty members from the Carey Business School will include researchers Ge Bai and Ozge Sahin. Jeremy Greene of the Johns Hopkins School of Medicine and Caleb Alexander of JHU’s Bloomberg School and medical s chool may even be a part of as skilled panelists. “Our discussions on the symposium shall be rooted in concepts of the social contract,” says Lee. “There are moral, authorized, and business issues that should be balanced. Solutions will remove barriers to take care of sufferers whose survival could rely upon access to these pharmaceuticals.” Lee was recently added to the roster for the celebrated Fulbright Specialist Program, an initiative of the United States Department of State. Her most recent research examines entry to trial drugs in terminal circumstances, proposing new tips to extend sufferers’ access. A member of the Carey Business School’s full-time school since 2008, Lee obtained her legislation degree from the University of Maryland School of Law in 1995. Before joining Carey, she worked as a trial lawyer and company in-house counsel. More information about the symposium or to register, go to/drug-accessibility-and-pricing-symposium. Posted 100 International Drive

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.